Abstract:Objective:To compare the regulating and protecting effects of rhein and simvastatin on dyslipidemia and renal injury in diabetic nephropathy. Methodology:Twenty-four db/db and db/m mouse with 8 weeks of age were divided into five groups according to their treatment ways: group A db/m was treated with saline; group B db/db with saline; group C db/db with rhein [150 mg/(kg·d)],and group D db/db was treated with simvastatin [20 mg/(kg·d)]. The body weight,plasma glucose,lipids level,24h urinary albumin excretion were measured every 4 weeks. The morphometry and immunohistology of transforming growth factor-β_1(TGF-β_1) and fibronectin (FN) were performed in all groups at the end of the study. Results:The plasma levels of cholesterol,triglyceride,low density lipoprotein and ApoE were all decreased in groups C and D than that in group B after treatment of 8 weeks. Urinary albumin excretion were reduced after treatment of 8 weeks in groups C and 12 weeks in groups D compared with group B (P<0.05). The morphometric analysis revealed that the glomerular tuft area (GTA) and extracellular matrix area (ECMA) were significantly decreased in groups C but not in group D compared with that in diabetic control group at age of 20 weeks. In immunohistochemistry,TGF-β_1 and FN expression of renal tissue was markedly decreased in groups C compared with that in group B at 20 weeks (P<0.05),but they were not significantly decreased in group D (P>0.05). Conclusion:Our data suggested that rhein has a similar effect to simvastatin on regulating dyslipidemia in diabetic db/db mouse. However,rhein also presents a more effective renal protection than simvastatin in diabetic nephropathy.

Comparative effects of rhein and simvastatin on dyslipidemia and diabetic nephropathy in db/db mouse